2025

Renon, Silvia, Ramses, Rafic, Aggarwal, Ankush ORCID: https://orcid.org/0000-0002-1755-8807, Good, Richard and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669 (2025) Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice? Frontiers in Medical Technology, 7, 1546417. (doi: 10.3389/fmedt.2025.1546417)

Carberry, J. et al. (2025) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, 27(3), pp. 566-576. (doi: 10.1002/ejhf.3560) (PMID:39675781) (PMCID:PMC11955320)

2024

Ang, D. T.Y. et al. (2024) Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial. Heart, (doi: 10.1136/heartjnl-2024-324677) (PMID:39603791) (Early Online Publication)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Ramses, Rafic, Kennedy, Simon ORCID: https://orcid.org/0000-0003-0887-5840, Good, Richard, Oldroyd, Keith G. and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669 (2024) Performance of drug-coated balloons in coronary and below-the-knee arteries: anatomical, physiological and pathological considerations. Vascular Pharmacology, 155, 107366. (doi: 10.1016/j.vph.2024.107366) (PMID:38479462)

2023

Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)

Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13(15), 2612. (doi: 10.3390/diagnostics13152612) (PMID:37568975) (PMCID:PMC10417445)

Collison, D. et al. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16(4), e012511. (doi: 10.1161/CIRCINTERVENTIONS.122.012511) (PMID:36974680) (PMCID:PMC10101135)

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)

2022

Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)

Articles

Renon, Silvia, Ramses, Rafic, Aggarwal, Ankush ORCID: https://orcid.org/0000-0002-1755-8807, Good, Richard and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669 (2025) Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice? Frontiers in Medical Technology, 7, 1546417. (doi: 10.3389/fmedt.2025.1546417)

Carberry, J. et al. (2025) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, 27(3), pp. 566-576. (doi: 10.1002/ejhf.3560) (PMID:39675781) (PMCID:PMC11955320)

Ang, D. T.Y. et al. (2024) Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial. Heart, (doi: 10.1136/heartjnl-2024-324677) (PMID:39603791) (Early Online Publication)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Ramses, Rafic, Kennedy, Simon ORCID: https://orcid.org/0000-0003-0887-5840, Good, Richard, Oldroyd, Keith G. and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669 (2024) Performance of drug-coated balloons in coronary and below-the-knee arteries: anatomical, physiological and pathological considerations. Vascular Pharmacology, 155, 107366. (doi: 10.1016/j.vph.2024.107366) (PMID:38479462)

Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)

Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13(15), 2612. (doi: 10.3390/diagnostics13152612) (PMID:37568975) (PMCID:PMC10417445)

Collison, D. et al. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16(4), e012511. (doi: 10.1161/CIRCINTERVENTIONS.122.012511) (PMID:36974680) (PMCID:PMC10101135)

Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)

Conference or Workshop Item

Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)